This trial is active, not recruiting.

Condition chronic hepatitis
Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Start date May 2014
End date December 2015
Trial size 500 participants
Trial identifier NCT02143180, ThirdSunYatSen


Our study is a prospective multicenter research and the aim is to explore a variety of suitable evaluation indicators and criteria for diagnosis of diffuse liver fibrosis, to get the corresponding diagnosis threshold, with the domestic common pathological S stages as the gold standard.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective

Primary Outcomes

Liver Fibrosis Index (LFI)
time frame: During the examination

Eligibility Criteria

Male or female participants from 5 years up to 70 years old.

Inclusion Criteria: - 1. Patient has a history of chronic hepatitis on clinical diagnosis; 2. Patient undergoed liver biopsy during study time. Exclusion Criteria: - 1. Patient cannot receive examination due to critical condition; 2. Patient refuse the examination.

Additional Information

Official title Accuracy of Real-time Tissue Elastography for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter Study.
Principal investigator Rogqin RQ Zheng, doctor
Trial information was received from ClinicalTrials.gov and was last updated in May 2014.
Information provided to ClinicalTrials.gov by Third Affiliated Hospital, Sun Yat-Sen University.